cancer therapetics
Infographic: Inside Melanoma Invasion
Infographic: Inside Melanoma Invasion
Catherine Offord | Mar 31, 2017
See what cytokine activity and cellular starvation have to do with cancer metastasis.
Turning Tumor Cells Against Cancer
Turning Tumor Cells Against Cancer
Anna Azvolinsky | Feb 8, 2016
In mice, cancer cells genetically modified to express an anticancer cytokine home to tumors and can reduce their growth. 
Radiation-Fighting Drug
Radiation-Fighting Drug
Rina Shaikh-Lesko | May 16, 2014
A hydroxylase inhibitor that prolongs the action of a gut-protective protein shows promise in mice as a treatment for radiation poisoning.
Nano-vehicles for Cancer Drugs
Nano-vehicles for Cancer Drugs
James Netterwald | May 20, 2013
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
AACR Talk
AACR Talk
The Scientist Staff | Apr 11, 2013
Some notable quotes from this week’s meeting on cancer research
Chicken Virus Attacks Cancer Cells
Chicken Virus Attacks Cancer Cells
Bob Grant | Apr 9, 2013
Researchers have genetically engineered a virus that is deadly to chickens and found that it can kill prostate cancer in vitro.
Q&A: The Cancer Tradeoff
Q&A: The Cancer Tradeoff
Chris Palmer | Apr 3, 2013
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Models of Transparency
Models of Transparency
Joan K. Heath, Richard White, Kirsten C. Sadler, David Langenau | Apr 1, 2013
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Funding Mishaps Rattle Review Panel
Funding Mishaps Rattle Review Panel
Dan Cossins | Oct 16, 2012
Every member of the scientific review panel at Texas’s $3-billion cancer research funding agency has quit, citing concerns about a lack of proper peer review.
Cancer-Fighting Virus
Ruth Williams | Jun 13, 2012
A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.